As illustrated above, ccRCC-01 was identified as ICB responsive CD8+ inflamed subtype while ccRCC-02 was identified as ICB resistant VEGF immune desert subtype.18 The gene discussed is VEGFA; the disease is nonpapillary renal cell carcinoma.